Stockreport

BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies

BioCardia, Inc.  (BCDA) 
PDF SAN CARLOS, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a company focused on developing cellular and cell-derived therapeutics for the tr [Read more]